论文部分内容阅读
对255例消化性溃疡(PU)进行临床研究,洛赛克与其他治疗PU的药物相较,其最宝贵的优点在于能更快地促进PU、特别是十二指肠溃疡(DU)的愈合,为病人赢得了宝贵的时间。洛赛克20mg/日治疗DU,2周愈合率88.6%,较泰胃美治疗4周的效果为优(P<0.005)。洛赛克治疗胃溃疡(GU)的效果虽不如DU,但溃疡2周愈合率仍与泰胃美治疗4周愈合率相似。对并发出血者止血效果好,无明显副作用,3例白细胞降低者对治疗耐受良好。
In a clinical study of 255 patients with peptic ulcer disease (PU), Losec has the most valuable advantage over other PU-treated drugs in promoting the healing of PU, especially duodenal ulcers (DU) more rapidly , Won the precious time for the patient. Losec 20mg / day treatment of DU, 2 weeks healing rate of 88.6%, compared with Tai Weimei treatment for 4 weeks was excellent (P <0.005). Although the effect of Losec in treating gastric ulcer (GU) was not as good as that of DU, the healing rate of 2-week ulcer was still similar to that of Tai-Wei Mei for 4 weeks. Bleeding hemorrhage on the effect of good, no significant side effects, 3 patients with leukopenia well treated.